sec filing
AI
NASDAQ · AIMD
Ainos, Inc.
Healthcare · Biotechnology
$1.33
Down-$0.04 (-3.01%)
Updated Oct 6, 2026, 11:44 PM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 7.91M
- P/E ratio
- -0.5
- Dividend yield
- 0.00%
- 52-week range
- $1.20 – $4.44
- Volume
- 30.3K
- Avg. volume
- 660.22K
Price performance · AIMD
AIMD price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
AIMD closed at $1.33 after 20 trading sessions, down 10.14% for the selected period.
- Last close
- $1.33
- Period change
- -10.14%
- Period low
- $1.24
- Period high
- $1.49
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $1.349 | $1.37 | $1.3117 | $1.33 | 30.3K |
| Oct 2, 2026 | $1.33 | $1.40 | $1.33 | $1.353 | 51.19K |
| Oct 1, 2026 | $1.27 | $1.3599 | $1.2603 | $1.30 | 41.9K |
| Sep 30, 2026 | $1.33 | $1.36 | $1.22 | $1.27 | 136.98K |
| Sep 29, 2026 | $1.34 | $1.385 | $1.20 | $1.24 | 227.02K |
| Sep 28, 2026 | $1.31 | $1.40 | $1.30 | $1.33 | 82.31K |
| Sep 25, 2026 | $1.37 | $1.41 | $1.32 | $1.34 | 162.49K |
| Sep 24, 2026 | $1.26 | $1.53 | $1.25 | $1.44 | 5.9M |
| Sep 23, 2026 | $1.37 | $1.45 | $1.37 | $1.395 | 27.12K |
| Sep 22, 2026 | $1.48 | $1.48 | $1.37 | $1.41 | 41.77K |
| Sep 21, 2026 | $1.47 | $1.48 | $1.40 | $1.46 | 43.19K |
| Sep 18, 2026 | $1.46 | $1.49 | $1.3801 | $1.48 | 51.66K |
| Sep 17, 2026 | $1.45 | $1.49 | $1.3658 | $1.49 | 31.85K |
| Sep 16, 2026 | $1.37 | $1.4997 | $1.34 | $1.38 | 67.66K |
| Sep 15, 2026 | $1.40 | $1.40 | $1.35 | $1.37 | 26.48K |
| Sep 14, 2026 | $1.415 | $1.4299 | $1.37 | $1.37 | 35.78K |
| Sep 11, 2026 | $1.48 | $1.48 | $1.40 | $1.44 | 23.2K |
| Sep 10, 2026 | $1.45 | $1.46 | $1.4201 | $1.43 | 14.65K |
| Sep 9, 2026 | $1.49 | $1.52 | $1.46 | $1.48 | 34.23K |
| Sep 8, 2026 | $1.60 | $1.60 | $1.475 | $1.48 | 41.54K |
Latest AIMD news
The latest Smart Investors Daily articles mentioning AIMD.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…